Evidence map›Paper›PMID 36593787›Full record

ArticleBulletin of the World Health Organization2023

Tuberculosis treatment outcomes and patient support groups, southern India.

Rajaram Subramanian Potty, Karthikeyan Kumarasamy, Joseph F Munjattu, Ramesh C Reddy, Rajesham Adepu, Anil Singarajipura, Mohan H Lakkappa, Reuben Swamickan, Amar Shah, Vikas Panibatla and 1 more

Abstract read
In one paragraph

Article in Bulletin of the World Health Organization, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rajaram Subramanian PottyKarnataka Health Promotion Trust (KHPT), IT Park, Rajajinagar Industrial Area, Behind KSSIDC Administration Office, Rajajinagar, Bengaluru, Karnataka, India560044.
Karthikeyan KumarasamyKarnataka Health Promotion Trust (KHPT), IT Park, Rajajinagar Industrial Area, Behind KSSIDC Administration Office, Rajajinagar, Bengaluru, Karnataka, India560044.
Joseph F MunjattuKarnataka Health Promotion Trust (KHPT), IT Park, Rajajinagar Industrial Area, Behind KSSIDC Administration Office, Rajajinagar, Bengaluru, Karnataka, India560044.
Ramesh C ReddyOffice of the Joint Director, Lady Willingdon State TB Centre, Bengaluru, India.
Rajesham AdepuOffice of the Joint Director, Commissionerate of Health and Family Welfare, Hyderabad, India.
Anil SingarajipuraOffice of the Joint Director, Lady Willingdon State TB Centre, Bengaluru, India.
Mohan H LakkappaKarnataka Health Promotion Trust (KHPT), IT Park, Rajajinagar Industrial Area, Behind KSSIDC Administration Office, Rajajinagar, Bengaluru, Karnataka, India560044.
Reuben SwamickanTuberculosis and Infectious Diseases Division, United States Agency for International Development India, New Delhi, India.
Amar ShahTuberculosis and Infectious Diseases Division, United States Agency for International Development India, New Delhi, India.
Vikas PanibatlaTB Alert India, Hyderabad, India.
Reynold WashingtonSt John's Research Institute, Bengaluru, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To assess treatment outcomes in tuberculosis patients participating in support group meetings in five districts of Karnataka and Telangana states in southern India. Methods: Tuberculosis patients from five selected districts who began treatment in 2019 were offered regular monthly support group meetings, with a focus on patients in urban slum areas with risk factors for adverse outcomes. We tracked the patients' participation in these meetings and extracted treatment outcomes from the Nikshay national tuberculosis database for the same patients in 2021. We compared treatment outcomes based on attendance of the support groups meetings. Findings: Of 30 706 tuberculosis patients who started treatment in 2019, 3651 (11.9%) attended support groups meetings. Of patients who attended at least one support meeting, 94.1% (3426/3639) had successful treatment outcomes versus 88.2% (23 745/26 922) of patients who did not attend meetings (adjusted odds ratio, aOR: 2.44; 95% confidence interval, CI: 2.10-2.82). The odds of successful treatment outcomes were higher in meeting participants than non-participants for all variables examined including: age ≥ 60 years (aOR: 3.19; 95% CI: 2.26-4.51); female sex (aOR: 3.33; 95% CI: 2.46-4.50); diabetes comorbidity (aOR: 3.03; 95% CI: 1.91-4.81); human immunodeficiency virus infection (aOR: 3.73; 95% CI: 1.76-7.93); tuberculosis retreatment (aOR: 1.69; 1.22-2.33); and drug-resistant tuberculosis (aOR: 1.93; 95% CI: 1.21-3.09). Conclusion: Participation in support groups for tuberculosis patients was significantly associated with successful tuberculosis treatment outcomes, especially among high-risk groups. Expanding access to support groups could improve tuberculosis treatment outcomes at the population level.

Indexed as

TuberculosisFemaleHumansIndiaMiddle AgedRisk FactorsSelf-Help GroupsTreatment Outcome

Identifiers

PMID36593787
PMCPMC9795383

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.